|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of debt issuance costs | |||||
| Gain on disposals of property, plant and equipment | |||||
| Impairment charges | |||||
| Non-cash lease expense | |||||
| Stock based compensation | |||||
| Deferred income taxes | |||||
| Changes in operating assets and liabilities: | |||||
| Receivables | |||||
| Inventories | |||||
| Other current assets, net | |||||
| Accounts payable | |||||
| Income tax receivable / payable | |||||
| Accrued expenses and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash Flows From Investing Activities | |||||
| Purchases of property, plant and equipment | |||||
| Proceeds from insurance | |||||
| Proceeds from the sale of property, plant and equipment | |||||
| Net cash used in investing activities | |||||
| Cash Flows From Financing Activities | |||||
| Payments of long-term debt | |||||
| Advances on line of credit | |||||
| Proceeds from exercise of stock options | |||||
| Repurchases of common stock | |||||
| Employee taxes paid for shares withheld | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents beginning of period | |||||
| Cash and cash equivalents end of period | |||||
| Cash and cash equivalents | |||||
| Supplemental disclosure of cash flow information | |||||
| Purchases of property, plant and equipment included in accounts payable and accrued expenses | |||||
| Cash paid for interest | |||||
| Cash paid (received) for income taxes, net of refunds | |||||
Loading...